Pharmaceutical composition capable of effectively preventing SN triple bond structure compound from inactivating and enhancing targeting activity

The invention relates to the technical field of medicines, in particular to a pharmaceutical composition capable of effectively preventing an SN triple bond structure compound from inactivating and enhancing targeting activity. The pharmaceutical composition comprises an SN triple bond structure compound, a stable protective agent and pharmaceutical excipients. The pharmaceutical composition disclosed by the invention ingeniously solves the problems of proton deficiency and water shortage of an environment in which an SN triple-bond compound is located, and failure of reaction of hydrophobicity, targeting, acid avoidance and other reactants of the composition, and lays a foundation for well and effectively applying the pharmaceutical composition to anti-tumor medicines and the like in the later period..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 05. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

HAO WEI [VerfasserIn]
HAO YANGFAN [VerfasserIn]
QIAO YALI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-05-05, Last update posted on www.tib.eu: 2023-09-26, Last updated: 2023-09-29

Patentnummer:

CN116059363

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA00224120X